IMWG Conference Series: ASCO & EHA 2023
Making Sense of Myeloma Treatment
Thursday, June 15, 2023
9:00 AM PST/10:00 AM MDT
11:00 AM CT/12:00 PM ET
At the upcoming IMWG Conference Series, “Making Sense of Treatment,” leading myeloma experts will discuss the latest drug therapy news from the June 2023 American Society of Clinical Oncology (ASCO) Annual Conference, IMF IMWG Summit, and the European Hematology Association (EHA) Annual Conference.
IMF Chairman of the Board Dr. Brian G.M. Durie will moderate the discussion, with Drs. María V. Mateos (University of Salamanca—Salamanca, Spain) and Thomas Martin (University of California San Francisco—San Francisco, CA) serving as panelists.
Dr. Durie will open the session by discussing the large number of myeloma abstracts from the ASCO and EHA annual conferences this year. He will then share highlights from the IMF IMWG Summit.
The panel and Dr. Durie focused on the following topics:
The latest data and advances with immunotherapies, both in CAR T-cell and bispecific therapies
Minimal Residual Disease in Myeloma: How to manage both MRD-negative and MRD-positive patients?
Managing early and later relapse in patients
The future use of Mass Spectrometry in the assessment of patient outcomes
Recommendations for myeloma patients for COVID-19 safety, and much more!
With Support from:
Janssen Oncology, Karyopharm, Sanofi and Takeda Oncology